US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

34.96

-0.1032-0.29%

Post-market: 35.000.0428+0.12%16:10 EDT

Volume:2K

Turnover:66.28K

Market Cap:16.43M

PE:- -

High:35.10

Open:35.10

Low:34.96

Close:35.06

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.73

T/O Rate:0.40%

Dividend:0.41

Dividend Rate:1.17%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

Citi sees limited immediate downside for Ionis after pelacarsen failure

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Novartis India - Deal Valued at 12.50 Bln Rupees

THOMSON REUTERS

Novartis Shares to Take Hit from Cholesterol Trial Failure

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Dow Jones Top Company Headlines at 9 PM ET: Amazon Cargo Plane Overshoots Runway in Miami, Killing Five People | Carmakers ...

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing

Innovative Drug Indices Rally, ETFs See Inflows, CXO and Research Services Show Strong Momentum

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/MEDX/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9572,"timestamp":1789156800000,"preClose":35.0604,"halted":0,"volume":1892,"hourTrading":{"tag":"盘后","latestPrice":35,"preClose":34.9572,"latestTime":"16:10 EDT","volume":8,"amount":279.3488,"timestamp":1789157404699,"change":0.0428,"changeRate":0.001224,"amplitude":0},"delay":0,"changeRate":-0.002943491802717626,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Market Closed","change":-0.1032,"latestTime":"09-11 16:00:00 EDT","open":35.1,"high":35.1,"low":34.9572,"amount":66279,"amplitude":0.004073,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.0604,"sharesOutstanding":569946,"nav":35.04,"aum":16466907.84,"dividendRate":0.011734,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35,"preClose":34.9572,"latestTime":"16:10 EDT","volume":8,"amount":279.3488,"timestamp":1789157404699,"change":0.0428,"changeRate":0.001224,"amplitude":0},"volumeRatio":0.7312359869705651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7312359869705651,"shares":469946,"dividePrice":0.4102,"high":35.1,"amplitude":0.004073,"preClose":35.0604,"low":34.9572,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9572,"eps":0,"divideRate":0.011734,"volume":1892,"delay":0,"ttmEps":0,"open":35.1,"prevYearClose":33.2024,"prevWeekClose":36.6906,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":37.0834,"twentyDayClose":35.9599,"sixtyDayClose":34.1895},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665176793","title":"Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321","url":"https://stock-news.laohu8.com/highlight/detail?id=2665176793","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665176793?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:20","pubTimestamp":1788794419,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) reported that pelacarsen’s Phase 3 HORIZON study failed to demonstrate a statistically significant reduction in major adverse ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4588","BK4585","PPH","BK4578","LU0211331839.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0208291251.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","MEDX","BK4532","IE0009355771.USD","LU0320765489.SGD","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665552317","title":"Citi sees limited immediate downside for Ionis after pelacarsen failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665552317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665552317?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:15","pubTimestamp":1788794109,"startTime":"0","endTime":"0","summary":"After Ionis’ (IONS) partner Novartis (NVS) disclosed that the pelacarsen Phase 3 Lp(a)HORIZON study failed to meet its primary endpoint of cardiova...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IE0002141913.USD","BK4585","LU0211331839.USD","IE00B2B36J28.USD","IE0009355771.USD","IONS","IE00BFTCPJ56.SGD","BK4532","LU0070302665.USD","PPH","IE00BJJMRZ35.SGD","NVS","IE00BJT1NW94.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","BK4588","MEDX","LU0320765489.SGD","BK4578","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311682","title":"BofA sees low single-digit percentage downside for Novartis on pelacarsen miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311682?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:00","pubTimestamp":1788782433,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) announced pelacarsen missed its primary endpoint of reducing cardiovascular events in the Phase 3 HORIZON study, BofA sees low...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVS","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","PPH","IE0002141913.USD","IE0009355771.USD","LU0070302665.USD","MEDX","BK4588","BK4532","IE00BFTCPJ56.SGD","BK4007","BK4578","LU0320765489.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0262","BK1574","IBBQ","MEDX","688488","LNGR","BK1161","159992","KSTR","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU2328871848.SGD","LU1969619763.USD","MEDX","LU2148510915.USD","09995","BK1583","IBBQ","BK0239","KSTR","159992","LU1064131003.USD","688331","LNGR","BK1161","LU2488822045.USD","BK1574","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0133085943.USD","LU0683600562.USD","LU2750360997.AUD","LU0823434740.USD","LU1551013425.SGD","LU2462157665.USD","LU0353189763.USD","LU2756315318.SGD","LU0320765992.SGD","LU0158827948.USD","LU2023251221.USD","LU0689472784.USD","IE00BFSS8Q28.SGD","LU1145028129.USD","LU2361044865.SGD","LU0471298777.SGD","LU0708995401.HKD","LU1291159041.SGD","LU0234572021.USD","LU0289739699.SGD","LU2491050071.SGD","LU1691799644.USD","LU2602419157.SGD","LU1267930730.SGD","IE0002141913.USD","LU1917777945.USD","BK4581","MEDI","WDNA","LU1127390331.HKD","IE0005OL40V9.USD","LU1712237335.SGD","LLY","IE00B775H168.HKD","LU0109394709.USD","LU0238689110.USD","IE00B7KXQ091.USD","LU0820562030.AUD","LU1988902786.USD","SG9999015978.USD","LU2750360641.GBP","BK4516","IE0001KFT4U8.USD","FHLC","LU1093756168.USD","IE0009355771.USD","LU0466842654.USD","LU0094547139.USD","LU1323610961.USD","IHE","LU1814569148.SGD","LU2468319806.SGD","PJP","IE00B2B36J28.USD","LU2264538146.SGD","SG9999018857.SGD","LLII","LU2168563687.JPY","HRTS","LU0385154629.USD","THNR","BK4588","LU0432979614.USD","LU0823416689.USD","LU2063271972.USD","LU2324357040.USD","MEDX","LU0889565916.HKD","LU1035775433.USD","SG9999017495.SGD","LU2756315664.SGD","LU2168564222.USD","LU2462591350.SGD","SGXZ81514606.USD","IE00BFSS7M15.SGD","LU0256863811.USD","LU0672654240.SGD","LU0456855351.SGD","LU1804176565.USD","VHT","LU0198837287.USD","FTXH","LU0158827781.USD","LU0786609619.USD","LU0820561818.USD","LU1064131342.USD","OZEM","SGXZ51526630.SGD","IE0004445239.USD","LU1983299246.USD","SG9999014880.SGD","AGNG","IE00B4R5TH58.HKD","LU2168564149.EUR","IE00BK4W5M84.HKD","ILDR","LU2168564065.EUR","LU2089283258.USD","LU2028103732.USD","LU2237438978.USD","LU2361044949.HKD","LU0882574055.USD","TMED","LU1623119135.USD","LU2896262040.SGD","LU1868836591.USD","LU0266013472.USD","LU0820561909.HKD","JDOC","IXJ","LU2237443895.HKD","SGXZ57979304.SGD","LU1974910355.USD","LU1551013342.USD","LU2089984988.USD","LU0823434583.USD","LU0345770308.USD","LU1057294990.SGD","LU2552382058.USD","RXL","BK4533","LU0354030511.USD","LU0353189680.USD","LU2361045086.USD","PPH","IE00BJT1NW94.SGD","LU0323591593.USD","LU2471134796.USD","IE00BK4W5L77.USD","LU0061475181.USD","LU2112291526.USD","BK4007","LU0109391861.USD","LU2360106947.USD","SG9999001176.USD","SG9999015986.USD","LU1868837136.USD","LU1093756325.SGD","BK4534","LU0097036916.USD","IE00BJJMRX11.SGD","CURE","LU1061106388.HKD","SGXZ31699556.SGD","SG9999018865.SGD","LU0640476718.USD","BK4211","LU2456880835.USD","GB00BDT5M118.USD","LU2357305700.SGD","LU2552382132.HKD","MHIP","SG9999015945.SGD","LU0787776722.HKD","LU1366192091.USD","LU2236285917.USD","SG9999014898.SGD","LU1023059063.AUD","SG9999001176.SGD","IE00B4JS1V06.HKD","IE00BKPKM429.USD","LU0106261372.USD","LU2271345857.HKD","TRUH","LU1069344957.HKD","BK4585","LU0943347566.SGD","LU0225283273.USD","LU2746668461.USD","XLV","LU1548497426.USD","IE00BJLML261.HKD","LLYX","LU1280957306.USD","LU0058720904.USD","LU2237443382.USD","LU0345770993.USD","LU1979441026.SGD","BK4599","LU1989771016.USD","LU2491050154.USD","LU2417539215.USD","GDOC","LU0122379950.USD","LU2471134879.HKD","LU0882574139.USD","SG9999014906.USD","LU0256863902.USD","IE00BFTCPJ56.SGD","IE00BKDWB100.SGD","LU0096364046.USD","ASB","LU0320765059.SGD","LU2089284900.SGD","LU2237443465.HKD","SG9999014914.USD","LU0316494557.USD","LU0417517546.SGD","LU0174119429.USD","LU2237443549.SGD","LU2746668974.SGD","LU0203202063.USD","LU1868836914.USD","LU2265009873.SGD","CANC","LU0079474960.USD","IYH","LU1232071149.USD","LU2213496289.HKD","LU2491049909.HKD","LU1868837300.USD","LU2023250504.SGD","LU0964807845.USD","LU2237443622.USD","SG9999013999.USD","LU2237443978.SGD","SG9999015952.SGD","LU0114720955.EUR","LLYZ","LU0006306889.USD","LU2168564495.EUR","LU2111349929.HKD","SGXZ99366536.SGD","LU2087625088.SGD","LU2211815571.USD","ELIS","LU0471298694.HKD","LU2471134523.USD","LU1868836757.USD","LU2461242641.AUD","LU0203201768.USD","LU0210536198.USD","LU1720051017.SGD","LU1629891620.HKD","LU2108987350.USD","IE0004445015.USD","IE00BN29S564.USD","IE00BJJMRY28.SGD","IE00BWXC8680.SGD","LU2471134952.CNY","LU0354030438.USD","LU2552382215.SGD","IE00B1BXHZ80.USD","IE00B1XK9C88.USD","LU1720051108.HKD","IE00BJJMRZ35.SGD","LU2106854487.HKD","LU2023250330.USD","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182662414","title":"Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future","url":"https://stock-news.laohu8.com/highlight/detail?id=1182662414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182662414?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:21","pubTimestamp":1788769307,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Anglikang Pharmaceutical Co.,Ltd. (002940.SZ) briefly hit the daily limit up on September 4th, buoyed by news of medical insurance negotiations and the launch of commercial...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1574","159992","BK1161","06978","IBBQ","MEDX","002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LU2089284900.SGD","MEDI","MHIP","BBH","IYH","PJP","BIB","LU1571399168.USD","LLY","VHT","JDOC","TRUH","FHLC","IE00BJJMRY28.SGD","LLYX","SGXZ99366536.SGD","WDNA","IBB","LU1691799644.USD","RXL","PBE","SLN","XLV","LU2361044865.SGD","OZEM","PPH","ELIS","LU1267930730.SGD","MEDX","LU0823434583.USD","LU0097036916.USD","FTXH","IXJ","NAMS","LLYZ","AMGN","LU2750360641.GBP","AGNG","GDOC","IBBQ","TBXU","CANC","TMED","HRTS","THNR","LLII","ILDR","IHE","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665572390","title":"Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665572390","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665572390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:03","pubTimestamp":1788768180,"startTime":"0","endTime":"0","summary":"Novartis shares fell after the Swiss drugmaker said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial.Shares in Novartis were down 3.2% in European morning t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","BK4532","LU0320765489.SGD","LU0211331839.USD","BK4007","IE00BJJMRZ35.SGD","IE0009355771.USD","NVS","IE0002141913.USD","BK4585","LU0070302665.USD","PPH","IE00B2B36J28.USD","BK4578","IE00B4R5TH58.HKD","MEDX","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","BK4592","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0868494617.USD","IE00BLSP4239.USD","SG9999001176.USD","BK4585","BK4532","IE00B19Z3B42.SGD","LU0225284248.USD","IE00B4R5TH58.HKD","PPH","LU0211331839.USD","LU0058720904.USD","BK4568","IE0009355771.USD","SGXZ57979304.SGD","LU0456855351.SGD","IE0002270589.USD","BK4534","BK4533","LU1066051498.USD","LU0070302665.USD","LU0320765489.SGD","BK4581","IE000M9KFDE8.USD","LU0321505868.SGD","LU2596442595.SGD","LU0170899867.USD","SG9999002224.SGD","BK4599","LU1883839398.USD","IE00BFTCPJ56.SGD","SG9999003800.SGD","NVS","BK4578","OZEM","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU0289739699.SGD","IE0002141913.USD","LU0985481810.HKD","LU1894683264.USD","SG9999002232.USD","LU1023059063.AUD","LU0234572021.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1894683348.USD","LU0306806265.USD","BK4550","LU0208291251.USD","IE00B3T34201.USD","LU0321505439.SGD","PFE","LU1066053197.SGD","LU0225771236.USD","LU0306807586.USD","BK4588","IE00B2B36J28.USD","LU0122379950.USD","SG9999001176.SGD","BK4007","IE00BBT3K403.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","IE00B2B36J28.USD","LU1983299246.USD","AMGN","BK4581","LU2468319806.SGD","BK4007","BK4532","LU2242646821.SGD","LU0289739699.SGD","LU0208291251.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE0002141913.USD","LU1057294990.SGD","LU2089984988.USD","LU2112291526.USD","BIB","BK4588","LU2242652126.USD","NVS","LU1061106388.HKD","BK4566","MEDX","IE00BJJMRZ35.SGD","LU0211331839.USD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","PPH","IBB","PBE","BK4578","LU0070302665.USD","PJP","IBBQ","BBH","TBXU","IE00BJT1NW94.SGD","BK4139","LU0868494617.USD","LU1023059063.AUD","SG9999001440.SGD","BK4534","BK4599","LU0109394709.USD","LU0122379950.USD","BK4533","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392965","title":"Novartis Heart-Trial Failure Could be Mitigated by Investor Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392965","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392965?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:04","pubTimestamp":1788764640,"startTime":"0","endTime":"0","summary":"0703 GMT - An experimental Novartis medicine missed the target in a late-stage clinical trial, but the hit to the Swiss drugmaker's share price could be mitigated by investors' skepticism about the study, analysts at Citi say in a research note. The drug, pelacarsen, reduced the levels of a fatty particle in the blood known as Lp, but this didn't translate to clinical outcomes, Citi says. \"We think market expectations of a positive trial were already cautious, with question marks around the magnitude of benefit and difficulty in commercialization even if the study had met the endpoint, which we think could limit the impact of the trial failure on the share price,\" the analysts say.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MEDX","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4588","IE00B2B36J28.USD","PPH","LU0320765489.SGD","BK4578","BK4585","IE0009355771.USD","IE0002141913.USD","NVS","IE00BJT1NW94.SGD","LU0211331839.USD","LU0070302665.USD","BK4532","LU0208291251.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665391143","title":"Novartis India - Deal Valued at 12.50 Bln Rupees","url":"https://stock-news.laohu8.com/highlight/detail?id=2665391143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665391143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:56","pubTimestamp":1788760577,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PPH","IE0009355771.USD","BK4588","IE00BFTCPJ56.SGD","LU0320765489.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4578","IE00BJT1NW94.SGD","NVS","LU0208291251.USD","BK4585","BK4532","IE0002141913.USD","BK4007","LU0211331839.USD","LU0070302665.USD","MEDX","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665684391","title":"Novartis Shares to Take Hit from Cholesterol Trial Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665684391","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665684391?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:43","pubTimestamp":1788759780,"startTime":"0","endTime":"0","summary":"0543 GMT - Novartis shares are likely to take a hit from news that a cholesterol drug candidate failed to reduce the risk of severe cardiovascular events like heart attacks and strokes in a late-stage trial, J.P. Morgan analysts say in a research note. Consensus estimates for Novartis included $1 billion in 2030 sales from the drug, called pelacarsen, the analysts say. Shares in the Swiss drugmaker are likely to be off 2% to 3% on Monday as a result, they add. Upcoming trial results for del-desiran, an experimental treatment for genetic neuromuscular disorder myotonic dystrophy type 1, are likely to be positive and could allow Novartis to more than erase stock weakness caused by the pelacarsen results, according to JPM.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Novartis Shares to Take Hit from Cholesterol Trial Failure","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU0208291251.USD","IE0002141913.USD","BK4007","LU0320765489.SGD","BK4585","LU0211331839.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4578","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","MEDX","BK4532","PPH","BK4588","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155170383","title":"Medical Device Inspection Campaign Launched by Ningyang County Market Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1155170383","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155170383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:41","pubTimestamp":1788756073,"startTime":"0","endTime":"0","summary":"On September 7, enforcement officers from the Market Supervision Administration of Ningyang County, Shandong Province, visited retail pharmacies within their jurisdiction to conduct a targeted...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDEV","HART","AGNG","BK1583","BK1100","PTH","09996","BK1574","159883","IEIH","LGHT","RSPH","LNGR","MEDX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894169","title":"MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894169?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754720,"startTime":"0","endTime":"0","summary":"As a wave of interim earnings reports floods in from medical device companies, the sector's recovery trajectory has become increasingly clear, with a definitive upward inflection point now visible in...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","BK1100","09996","02041","RSPH","BK4585","GDOC","159883","PTH","MDEV","AGNG","BK1583","MEDX","KCAI","LGHT","IEIH","LNGR","VXUS","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398915","title":"Dow Jones Top Company Headlines at 9 PM ET: Amazon Cargo Plane Overshoots Runway in Miami, Killing Five People | Carmakers ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398915?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:00","pubTimestamp":1788742800,"startTime":"0","endTime":"0","summary":"Amazon Cargo Plane Overshoots Runway in Miami, Killing Five PeopleMore than 60 Miami-Dade Fire Rescue units rushed to the scene to put out the flames and assess any injuries.----Carmakers Have a New I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0077335932.USD","LU1232071149.USD","LU0130103400.USD","TSLS","LU0208291251.USD","LU1815333072.USD","LU2317271919.USD","IE0002141913.USD","LU2023251221.USD","IE00BJJMRX11.SGD","LU0225771236.USD","LU2552382132.HKD","LU0289941410.SGD","LU0211327993.USD","IE00B7KXQ091.USD","LU2210150020.SGD","BK4585","LU0742534661.SGD","LU1046421795.USD","LU1791710400.SGD","BK4503","HK0000304805.HKD","SGXZ81514606.USD","SMOG","IE000F7OJYX1.SGD","IE00B19Z3B42.SGD","LU2471134523.USD","ELOL","LU1814569148.SGD","LU0642271901.SGD","BK4541","LU2242649171.HKD","BEG","LU1267930490.SGD","LU2362541513.USD","LU1720051017.SGD","AMAA","BK4604","CLIX","LU1244550577.SGD","IE000SO60NU8.SGD","IE00B2B36J28.USD","LU2750360641.GBP","XHB","LU0345770308.USD","BK4122","LU0203202063.USD","IE00B1XK9C88.USD","LU0788109477.HKD","LU0310799852.SGD","LU2361045086.USD","LU2168564495.EUR","BK4579","IE0005OL40V9.USD","LU0786609619.USD","ZAP","BE","LU2023250504.SGD","09366","09766","IE0009354923.USD","BK4550","LU2265009873.SGD","SGXZ51526630.SGD","LU1496350502.SGD","LU1803068979.SGD","LU1201861249.SGD","LU1037948897.HKD","LU2054465674.USD","LU0265550359.USD","LU2023250330.USD","LU1935042991.SGD","IE000W1ABFV2.USD","LU0882574139.USD","LU0174119429.USD","LU0348723411.USD","SG9999018857.SGD","LU0672654240.SGD","LU0072462426.USD","SG9999015952.SGD","BK4532","LU0965509010.AUD","LU1261432733.SGD","LU2326559502.SGD","LU0143551892.USD","LU2462591277.SGD","LU0719512351.SGD","IE00B775H168.HKD","LU2237957811.SGD","LU0444971666.USD","LU2487616109.SGD","LU2471134879.HKD","LU0157215616.USD","LU2458330243.SGD","BK4533","LU0070217475.USD","LU2471134952.CNY","BEZ","IE0009G5SDU7.USD","BK4007","IE00BMPRXN33.USD","IE00BJTD4N35.SGD","LU1066051811.HKD","LU1979441026.SGD","NVS","LU0965508806.USD","LU2420271590.USD","LU1244550494.USD","LU1244550221.USD","LU2250418816.HKD","LU2954938101.SGD","LU0472753341.HKD","LU2637965513.SGD","LU0210533765.USD","LU1815336760.USD","LU2461242641.AUD","IE00BMPRXQ63.HKD","LU0345768153.USD","LU0109392836.USD","EGGY","LU0211331839.USD","BK4598","LU2264538146.SGD","IE00B4YYXB79.USD","LU0127658192.USD","LU0980610538.SGD","BK4581","HYDR","AMZW","LU1861559042.SGD","LU2360107168.USD","LU0823414478.USD","LU0107464264.USD","LU2403377893.USD","LU1917777945.USD","LU0792757196.USD","IE00BWXC8680.SGD","LU1235294995.USD","LU2357125470.USD","AMZU","LU0823421416.USD","LU1623119135.USD","LU2247934214.USD","TSII","LU1935043023.USD","AMZN","LU1116320901.HKD","TSYY","LU0868494708.USD","LU2361044865.SGD","LU1548497426.USD","LU2065171402.SGD","BK4534","LU0170899867.USD","LU2168563687.JPY","LU2552382215.SGD","SG9999017495.SGD","BK4566","SG9999014914.USD","LU0238689110.USD","CTEC","LU2063271972.USD","LU0345768740.USD","TSLZ","FDRV","LU2168564065.EUR","LU0784383803.USD","LU0133085943.USD","LU0289961442.SGD","LU2089283258.USD","LU0306807586.USD","LU0708994859.HKD","LU1861127337.USD","LU0256863902.USD","LU0784385840.USD","IE000ITXATA3.USD","LU2092627202.USD","SG9999014906.USD","IE00B3S45H60.SGD","LU0256863811.USD","BK4524","LU0964807845.USD","LU2361044949.HKD","LU2211815571.USD","LU0823421333.USD","LU0320765059.SGD","LU2065170008.USD","LU1435385759.SGD","07766","IE00B1BXHZ80.USD","LU1868837300.USD","TSLW","LU2362541273.HKD","AMZD","LU1989764748.USD","IE000WAW04H5.SGD","IE00BFSS8Q28.SGD","LU0072461881.USD","LU1119994496.HKD","LU2756315318.SGD","LU0321505868.SGD","LU1720051108.HKD","LU1201861165.SGD","LU2125154778.USD","SGXZ99366536.SGD","SG9999015945.SGD","LU0345769128.USD","BK4182","TTD","F","LU0316494557.USD","TSLI","LU0056508442.USD","LU1366333091.USD","LU2456880835.USD","LU2417539215.USD","BK4528","AMZO","LU0784384876.USD","LU1629891620.HKD","BK4555","LU0265550946.USD","SGXZ44715902.SGD","LU2275660780.HKD","LU2764263039.SGD","IE00BJJMRY28.SGD","TSL","LU0081259029.USD","LU1691799644.USD","LU2028103732.USD","HK0000304797.USD","IE00BJT1NW94.SGD","SG9999000418.SGD","LU0312595415.SGD","LU0154236417.USD","LU0106261372.USD","LU1084165304.USD","LU2462157665.USD","LU0061475181.USD","IE00BK4W5M84.HKD","LU0820561818.USD","IE000KEQY171.SGD","LU0162691827.USD","ILDR","AMZZ","LU0820561909.HKD","LU2746668974.SGD","LU0724617625.USD","WANT","LU1035775433.USD","LU0557290698.USD","LU1914381329.SGD","LU0251131958.USD","LU0053666078.USD","LU1066051498.USD","LU1323610961.USD","VTWG","LU0320765489.SGD","STLA","BEX","IE00BKDWB100.SGD","LU1301847155.USD","LU1974910355.USD","LU0029864427.USD","IE0003U64NQ7.SGD","LU0069063385.USD","BK4543","LU0149725797.USD","LU0985481810.HKD","LU1791710582.SGD","LU0444973449.USD","IE00BQXX3C00.GBP","LU2092937148.SGD","LU2360106780.USD","LU0158827781.USD","LU0210528500.USD","LU0203201768.USD","LU2083900584.USD","ADBE","LU2452424414.USD","IE00BKPKM429.USD","USAW.SI","LU2362540622.SGD","AMZG","LU2213496289.HKD","TESC","LU1868836914.USD","LU0648000940.SGD","IBAT","IE00BZ1G4Q59.USD","TSLG","TEST","LU0138981039.USD","LU0985320562.USD","LU2896262040.SGD","LU0048584097.USD","LU1037948541.HKD","LU0345774391.USD","LU1868836757.USD","LU0225284248.USD","IE00B4JS1V06.HKD","LU1551013342.USD","LU2720916845.USD","AMZY","LU2430703251.USD","SG9999001077.SGD","TSLA","BK4527","BK4099","LU2108987350.USD","BK4567","LU1778281490.HKD","BK4596","SG9999014880.SGD","LU1267930573.SGD","BK4158","LU2764262908.HKD","LU0234570918.USD","LU0689472784.USD","IE000MB6IJN5.SGD","IE0009355771.USD","LU0648001328.SGD","IE00B5TLWC47.USD","LU1153585028.USD","IE00B19Z3581.USD","HK0000532082.HKD","LU0314104364.USD","PPH","LU1861215975.USD","GB00BDT5M118.USD","OGIG","LU0683600562.USD","LU2602419157.SGD","FRDU","LU0345769631.USD","LU0302445910.USD","LU0158827948.USD","LU2360032135.SGD","LU0957808578.USD","IE00BFTCPJ56.SGD","LU0342679015.USD","IE00BYQQ9H92.USD","IE00BJTD4V19.USD","LU0965509283.SGD","LU1551013425.SGD","LU2506951792.HKD","LU0823434583.USD","FRNW","LU1839511570.USD","IE00B19Z8W00.USD","LU0354030511.USD","LU0345774631.USD","LU1880398554.USD","HK0000914686.HKD","LU1934455277.USD","IE00B3SWFQ91.USD","LU0109391861.USD","LU0011850046.USD","LU1868836591.USD","LU0823434740.USD","LU2095319765.USD","LU0082616367.USD","SGXZ80539844.SGD","BK4613","LU0957791311.USD","BK4561","LU2999663052.SGD","LU1496350171.SGD","LU0061474705.USD","LU2458330169.SGD","IE0002270589.USD","IE00BSNM7G36.USD","LU1989764664.SGD","BEC","LU2077746001.SGD","LU2087621335.USD","IE00B4R5TH58.HKD","LU2430703178.SGD","LU2505996681.GBP","LU1861558580.USD","LU2106854487.HKD","TAP","LU1280957306.USD","LU1069344957.HKD","LU0708995401.HKD","LU1935043536.SGD","LU2271345857.HKD","SAMZNmain","MEDX","LU2249611893.SGD","LU0267386448.USD","TESL","LU0323591593.USD","LU2023250843.SGD","LU2237438978.USD","LU0276348264.USD","ICLN","LU0289960550.SGD","LU1642822529.SGD","BK4588","LU0096362180.USD","SGXZ31699556.SGD","SG9999002232.USD","UPGR","IE00BK4W5L77.USD","LU1267930730.SGD","LU2592432038.USD","LU1066051225.USD","LU1988902786.USD","BK4511","LU0289739343.SGD","LU0306806265.USD","BK4009","BK4592","BK4516","ADBU","LU0390134368.USD","SG9999002224.SGD","FRDD","TSDD","LU0787776722.HKD","LU0943347566.SGD","LU0868494617.USD","LU0353189763.USD","IE00BQXX3F31.USD","AZYY","IE0009356076.USD","LU2294711713.HKD","LU0861579265.USD","LU1127390331.HKD","BK4554","CNRG","LU0061474960.USD","LU2430703095.HKD","LU0251132253.USD","BK4548","LU0949170426.SGD","BK4535","LU1718418525.SGD","LU0234572021.USD","LU0456855351.SGD","LU0889565833.HKD","SGXZ23171101.USD","LU0823411888.USD","LU0079474960.USD","SG9999015978.USD","LU0006306889.USD","LU0048573561.USD","IE00B775SV38.USD","ADBG","BK4612","LU0353189680.USD","ONLN","IE00B3T34201.USD","LU1712237335.SGD","LU0057025933.USD","BK4507","LU1633808545.USD","LU1116320737.USD","SG9999004303.SGD","VCLN","SIMS","LU0097036916.USD","BLDR","LU0310800379.SGD","LU1934455194.USD","07366","LU2505996509.AUD","LU0175139822.USD","LU1267930813.SGD","LU0820562030.AUD","HK0000914660.USD","IE0004091025.USD","CRSH","STSLAmain","LU0528227936.USD","LU2860962120.EUR","BK4220","LU0210536198.USD","LU1366192091.USD","IE0004445015.USD","IE00BQXX3D17.EUR","BK4559","LU1880398471.USD","SG9999001424.SGD","AMZP","LU0198837287.USD","LU2210149790.SGD","LU2552382058.USD","LU0354030438.USD","LU2065171311.SGD","LU2543165471.USD","IE0004086264.USD","IE00BJJMRZ35.SGD","LIT","LU0784385170.HKD","LU2065169927.USD","LU0466842654.USD","SG9999018865.SGD","LU1852331112.SGD","LU2756315664.SGD","LU0070302665.USD","LU2089284900.SGD","LU2097829019.USD","IE000BZT7R73.USD","LU0308772762.SGD","IE0001KFT4U8.USD","LU2750360997.AUD","SG9999014898.SGD","LU1064927863.SGD","LU0417517546.SGD","LU0211328371.USD","IE0004445239.USD","IE00BFSS7M15.SGD","IE00B7SZLL34.SGD","LU0096364046.USD","LU1316542783.SGD","LU0942090050.USD","LU1861220033.SGD","BK4574","LU0130102774.USD","BK4551","LU1823568750.SGD","LU0128525929.USD","LU0476273544.USD","IE0000B7K699.USD","LU2236285917.USD","IE00BN29S564.USD","IE0034235303.USD","LU0511384066.AUD","IE00B19Z8X17.USD","LU1674673428.USD","LU1935042488.USD","LU0345770993.USD","LU0251142724.SGD","WATS","LU2746668461.USD","LU1934455863.HKD","LU2381873111.SGD","LU2211817866.USD","LU0640476718.USD","IE00BKVL7J92.USD","LU0823414551.USD","LU1064131342.USD","LU2357305700.SGD","LU1935042215.USD","LU1883839398.USD","IE00BFXG0V08.USD","LU2168564222.USD","BK4086","HULL","IE00B19Z9505.USD","IDRV","IE00B5949003.HKD","LU0494093205.USD","LU1674673691.USD","BK4538","TSLR","LU2087625088.SGD","LU1074936037.SGD","BK4578","LU1935043452.HKD","IE00BMPRXR70.SGD","TLA","LU2125154935.USD","LU1429558221.USD","TSLY","LU0080751232.USD","LU1066053197.SGD","LU2764263203.CNY","LU2111349929.HKD","IE00BJLML261.HKD","LU0871640123.AUD","LU0965509101.SGD","LU0321505439.SGD","LU2462591350.SGD","TSLL","TSLT","IE000YTNTUN2.SGD","TTDU","TSLO","LU2237957902.USD","SG9999015986.USD","LU0215105999.USD","LU2290526834.HKD","LU1868837136.USD","LU1804176565.USD","TSLQ","BK4023","IE000M9KFDE8.USD","LU0889566641.SGD","LU1145028129.USD","RTH","TSLP","LU2242650005.HKD","LU2168564149.EUR","LU2471134796.USD","LU2463028550.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184969761","title":"AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969761","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184969761?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:02","pubTimestamp":1788735760,"startTime":"0","endTime":"0","summary":"The innovative medicine sector is gaining significant momentum as artificial intelligence transforms the drug development landscape from discovery through clinical trials and regulatory approval. A...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06978","MEDX","BK1593","BK4588","CHAT","AIPO","BK1161","BK1515","VXUS","BK1574","BK4585","ARTY","02228","VTHR","QTOC","BK1617","159992","IBBQ","LNGR","03696","AGIX","BK1191","02196","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167267027","title":"Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=1167267027","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167267027?lang=en_us&edition=fundamental","pubTime":"2026-09-06 20:40","pubTimestamp":1788698452,"startTime":"0","endTime":"0","summary":"On September 6, Sichuan Biokin Pharmaceutical Co., Ltd. (688506) issued a notice confirming its participation in the Star Market’s collective earnings briefing for the innovation drug sector covering...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK0239","IBBQ","BK1161","688506","159992","91194","BK1574","KSTR","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122138400","title":"Innovative Drug Indices Rally, ETFs See Inflows, CXO and Research Services Show Strong Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1122138400","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122138400?lang=en_us&edition=fundamental","pubTime":"2026-09-06 10:40","pubTimestamp":1788662438,"startTime":"0","endTime":"0","summary":"Over the past three months, three major innovative drug indices—the Shanghai Stock Exchange STAR Innovative Drug Index, the CSI Innovative Drug Industry Index, and the Hang Seng HK Stock Connect...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WX","06978","BK1574","IBBQ","LNGR","BK4585","BK4550","FDN","BK1161","MEDX","CXO","159992","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":8,"totalSize":302,"code":"91000000","status":"200"}]}}